Xerostomia is a health condition characterised by oral dryness, often accompanied by salivary gland hypofunction. Common causes of xerostomia include autoimmune diseases (e.g., Sjögren’s syndrome), dehydration, diabetes, anxiety medications, antihypertensives, and head‑and‑neck radiation.
Did you know?
According to a 2018 systematic review, the estimated prevalence of xerostomia in the general population is around 22%. 1 The prevalence of xerostomia is higher in older individuals, largely due to medication use. (A 2021 review in Oral Diseases).2
Why Saliva Matters to the Oral Cavity?
Saliva is essential for maintaining oral health as it provides:3
- Starts the process of digestion by enzymatic action
- Lubrication for speech and swallowing
- Mechanical cleansing
- Antimicrobial activity
- Calcium and phosphate for remineralisation
According to a 2025 study, salivary flow rate is one of the strongest predictors of caries risk.4
How Does Xerostomia Increase Caries Risk?
When salivary flow decreases, the oral environment shifts dramatically:
- Rapid pH drop and prolonged acid exposure
- Increased plaque retention
- Reduced remineralization
- Overgrowth of cariogenic bacteria (e.g., Streptococcus mutans, Lactobacilli)
- Higher incidence of cervical and root caries, often progressing aggressively
Clinical Consequences of Xerostomia: Signs and Symptoms5
Patients with xerostomia may experience:
- Sense of dryness or burning in the mouth
- Reduced taste sensation
- The need to keep sipping water when swallowing food
- Thickened saliva
- Sensitivity to acidic or spicy foods
- Loss of appetite and weight loss
Clinical findings may include:
- Fissured tongue and lips
- Atrophy of the filiform papillae
- Erythematous and parched mucosa
- Increased incidence of root and coronal caries
- Higher risk of restoration failure
- Greater plaque accumulation and biofilm retention
- Prosthesis retention challenges
- Increased peri-implant complications in susceptible patients
Long-term loss of saliva's protective effects can negatively influence the longevity and predictability of dental treatments across restorative, prosthodontic, periodontal, and implant therapies.
How to Identify At-Risk Patients?
Effective evaluation includes:6
- Examination for mucosal dryness, stringy saliva, fissured tongue, and rampant caries patterns
- Medication review
- Patient‑reported dryness questionnaires
- Sialometry (resting and stimulated flow rates)
Caries Prevention Strategies: Evidence‑Based Interventions in
-
Salivary Stimulation
- Sugar‑free gum with xylitol
- Sialagogues (e.g., pilocarpine, cevimeline) when indicated6
- Frequent hydration
-
Use of Saliva Substitutes
- Carboxymethylcellulose‑based gels
- Mucin‑based substitutes
- Night‑time humidifier use
-
Fluoride Therapy
- 1000 ppm fluoride toothpaste
- Fluoride varnishes every 3–6 months
- Fluoride alcohol-free mouthwashes
-
Remineralization Agents
- Arginine + MFP
- CPP‑ACP (casein phosphopeptide–amorphous calcium phosphate)
- Calcium‑phosphate rinses
-
Diet Counseling
- Reduce fermentable carbohydrates
- Avoid acidic beverages
- Encourage non‑cariogenic snacks
- Prevention strategies
Patient Education Tips: Daily Habits That Make a Difference
- Sip water frequently
- Avoid alcohol‑based mouthwashes
- Use humidifiers at night
- Chew xylitol gum after meals
- Maintain strict oral hygiene
Why Fluoride Matters in Xerostomia Management
For patients with compromised salivary protection, topical fluoride plays a vital role in:
- Enhancing enamel remineralisation
- Increasing resistance to acid dissolution
- Protecting vulnerable root surfaces
- Supporting long-term caries prevention
Given the elevated caries risk associated with xerostomia, fluoride-based preventive protocols can be an important component of comprehensive patient management.
Support preventive care in high caries-risk patients
WITH
Colgate Phos.Flur®
The Acidulated Phosphate Fluoride (APF) alcohol-free formulation of Coglate Phos.Flur with 0.04% w/v Sodium Fluoride (NaF) composition enhances fluoride uptake and enamel resistance to caries.
Colgate Phos.Flur has shown to:
- Reduce white spot lesions by almost 58%
- Deliver superior gingival outcomes by lowering the GI score at 24 weeks with APF
- Cause a visible drop in ICDAF after 12 weeks with APF
It:
- Supports faster enamel remineralisation efforts
- Offers daily fluoride advantage
- Prevents white spot lesions
- Helps strengthen teeth against acid challenges
For patients whose natural salivary defences are compromised, integrating effective fluoride therapy into routine preventive care can help improve long-term oral health outcomes.
References:
- https://www.ada.org/resources/ada-library/oral-health-topics/xerostomia
- Thomson, W. M., Smith, M. B., Ferguson, C. A., & Moses, G. (2021). The challenge of Medication-Induced dry Mouth in residential aged care. Pharmacy, 9(4), 162. https://doi.org/10.3390/pharmacy9040162
- Saliva. (n.d.). MouthHealthy - Oral Health Information From the ADA. https://www.mouthhealthy.org/all-topics-a-z/saliva
- Shetty, J., Hegde, M. N., Kumari, N. S., D’Souza, N., & Shetty, S. S. (2025). Salivary analysis in adults with and without root caries in South coastal population of India - A cross-sectional analytical study. Journal of Conservative Dentistry and Endodontics, 28(5), 406–411. https://doi.org/10.4103/jcde.jcde_791_24
- Talha, B., & Swarnkar, S. A. (2023, March 24). Xerostomia. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK545287/
- Xerostomia (Dry mouth). (n.d.). American Dental Association. https://www.ada.org/resources/ada-library/oral-health-topics/xerostomia